Owen Stephens
University of Arkansas for Medical Sciences · 62 works · 3,770 citations · h-index 22
Top works
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
- High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2
- Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation
- Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
- The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells
- An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification
- Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
- Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker
- Prediction of cytogenetic abnormalities with gene expression profiles
- Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma
- Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
- Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy
- A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
- Kinase domain activation through gene rearrangement in multiple myeloma